Free Trial Information
BioCentury | Nov 10, 2014
Company News

Trino management update

Trino Therapeutics Ltd. , Dublin, Ireland Business: Inflammation, Gastrointestinal, Autoimmune Hired: Richard Davis as CEO, a newly created position, formerly healthcare investment manager at Wellcome Trust WIR Staff autoimmune Gastrointestinal Inflammation...
Read More
BioCentury | Jun 17, 2013
Emerging Company Profile

Trino: Planting GI health

...mucosal healing as effectively as standard steroid therapy while being safe enough for chronic use. Trino's...
...molecules ended up dimerizing instead, which gave us our new scaffold molecule," noted Neil Frankish, Trino's...
...Companies and Institutions Mentioned Trinity College Dublin , Dublin, Ireland Trino Therapeutics Ltd. , Dublin, Ireland Sidebars Trino Therapeutics Ltd....
Read More
BioCentury | Jun 3, 2013
Company News

Trino board of directors update

Trino Therapeutics Ltd. , Dublin, Ireland Business: Inflammation, Gastrointestinal Appointed: Ena Prosser, partner at Fountain Healthcare Partners; and Keith Spencer, business analyst at the Wellcome Trust WIR Staff Gastrointestinal Inflammation...
Read More
BioCentury | Jun 3, 2013
Financial News

Trino completes venture financing

Trino Therapeutics Ltd. , Dublin, Ireland Business: Inflammation, Gastrointestinal Date completed: 5/28/13 Type: Venture financing Raised: €9.2 million ($11.9 million) Investors: Wellcome Trust; Fountain Healthcare Partners; Enterprise Ireland; Growcorp Note: The round comprises a previously undisclosed...
Read More
BioCentury | May 29, 2013
Financial News

IBD co Trino raises EUR 9.2M series A

...Fountain Healthcare, and Keith Spencer, a business analyst at the Wellcome Trust, joined Trino's board. Trino...
Read More
Items per page:
1 - 5 of 5
BioCentury | Nov 10, 2014
Company News

Trino management update

Trino Therapeutics Ltd. , Dublin, Ireland Business: Inflammation, Gastrointestinal, Autoimmune Hired: Richard Davis as CEO, a newly created position, formerly healthcare investment manager at Wellcome Trust WIR Staff autoimmune Gastrointestinal Inflammation...
Read More
BioCentury | Jun 17, 2013
Emerging Company Profile

Trino: Planting GI health

...mucosal healing as effectively as standard steroid therapy while being safe enough for chronic use. Trino's...
...molecules ended up dimerizing instead, which gave us our new scaffold molecule," noted Neil Frankish, Trino's...
...Companies and Institutions Mentioned Trinity College Dublin , Dublin, Ireland Trino Therapeutics Ltd. , Dublin, Ireland Sidebars Trino Therapeutics Ltd....
Read More
BioCentury | Jun 3, 2013
Company News

Trino board of directors update

Trino Therapeutics Ltd. , Dublin, Ireland Business: Inflammation, Gastrointestinal Appointed: Ena Prosser, partner at Fountain Healthcare Partners; and Keith Spencer, business analyst at the Wellcome Trust WIR Staff Gastrointestinal Inflammation...
Read More
BioCentury | Jun 3, 2013
Financial News

Trino completes venture financing

Trino Therapeutics Ltd. , Dublin, Ireland Business: Inflammation, Gastrointestinal Date completed: 5/28/13 Type: Venture financing Raised: €9.2 million ($11.9 million) Investors: Wellcome Trust; Fountain Healthcare Partners; Enterprise Ireland; Growcorp Note: The round comprises a previously undisclosed...
Read More
BioCentury | May 29, 2013
Financial News

IBD co Trino raises EUR 9.2M series A

...Fountain Healthcare, and Keith Spencer, a business analyst at the Wellcome Trust, joined Trino's board. Trino...
Read More
Items per page:
1 - 5 of 5